Holy Basil (Tulsi): Stress Evidence and Comparing Extracts

What is holy basil?

Holy basil, called tulsi in India, is Ocimum tenuiflorum (also named Ocimum sanctum), a plant used in Ayurvedic medicine and drunk as tea. It is a different species from sweet basil (Ocimum basilicum), the kind used in cooking.

Two proprietary extracts—products made by a defined process and sold under their own names—have placebo-controlled trials at very different amounts: OciBest at 1,200 mg a day and Holixer at 125 mg twice a day (250 mg). Shops also sell whole-leaf powders and tea. There is no official daily amount.

People take holy basil for stress, sleep, and blood sugar. In two small trials, each funded or supplied by the extract’s maker, people rated their stress lower than with placebo. No research team unaffiliated with the makers has repeated either result.

Traditional uses and today's supplements

Tulsi belongs to both household religious practice and Indian medical traditions. The CBSE cultural account^[1] describes its worship as a manifestation of Lakshmi, its place near Hindu homes and temples, and the Tulsi Vivah ceremony. These are religious and cultural meanings attached to the living plant.

The IMPPAT institutional database^[2] records tulsi in Ayurveda, Siddha and Unani, among other systems. Its leaf entries include cough, fever, breathing difficulties, indigestion and gas; the cough entry cites the Ayurvedic Pharmacopoeia. Seed entries separately include digestive and laxative uses. These are compiled records of medicinal uses, not clinical trial results. Leaf remedies and teas also differ from the concentrated extracts used in modern trials. The traditional account also associates tulsi with wellbeing and longevity. Modern stress and cognition experiments have tested selected extracts over weeks; they have not measured rejuvenation or lifespan.

Rama, Krishna and Vana are useful names—but check the species

Rama usually refers to green-leaved tulsi and Krishna or Shyama to purple-tinged tulsi. Vana is commonly identified as Ocimum gratissimum, a different species. The institutional botanical account^[1] distinguishes these names. A “three tulsi” blend therefore needs more than a common name to match a trial of O. tenuiflorum.

A tea, a whole-leaf powder and a standardized extract also differ in what they contain. The two best-known stress trials used defined extracts at very different daily amounts.

What people take holy basil for

The two extract trials suggest modest relief of self-rated stress, but they do not establish that tea or generic leaf powder works the same way. Sweet basil, the cooking herb, is a different plant, so results do not transfer between the species.

For mild stress, weigh the possible benefit of the exact extract against evidence limited to small, maker-linked trials without independent replication. Tea remains a traditional food-like use, not a lower-dose version of the extract evidence.

When to ask a doctor before taking holy basil

• You take blood thinners or have surgery coming up. Clinical interaction evidence is sparse; tell the clinician managing your treatment or procedure about the exact preparation.
• You take diabetes medicine. Some studies have combined tulsi with diabetes drugs, but the effects and safety of your exact preparation and medicine combination are not established. Agree with the prescriber how to monitor blood sugar.

All forms at a glance

Milligrams do not carry over between these preparations. A 250 mg Holixer capsule is not a smaller version of 1,200 mg OciBest, and neither amount tells you how much leaf powder or tea to use.

What to pay attention to on the label

Which number on the label is the amount?

Look for the extract name and milligrams. One Holixer product lists 250 mg per capsule, taken “once or twice daily,” which is 250 to 500 mg a day. The trial used 250 mg a day, so twice daily doubles it.

Misleading labels

Leaf powder versus named extracts

A whole-herb capsule lists three 100 mg tulsi powders, 300 mg in total. A bulk powder lists 500 mg of “holy basil” with no species or extract detail. A “clinically studied” or “supports a healthy stress response” claim may refer to an OciBest or Holixer trial, each tied to the extract's maker. Presenting those findings beside a plain powder can make it appear backed by research on a different, concentrated extract.

Tulsi dust in a blend

In a stress blend, the holy basil name can draw attention to tulsi research even when its amount and extract identity are undisclosed. That prevents a meaningful assessment of what the featured ingredient contributes.

Confusing servings and items per serving

Some manufacturers put 180 capsules on the front, and the back says 3 capsules per serving and 60 servings. The amount on the Supplement Facts panel is for the whole 3-capsule serving.

An “adaptogen” claim

“Adaptogen” is a twentieth-century research term for substances proposed to increase resistance to stress. The name alone does not establish a clinical benefit or identify which tulsi extract was studied.

Common Myths about Holy basil

Is holy basil as good as ashwagandha?

Not shown. No trial has compared ashwagandha and holy basil. Ashwagandha has more stress trials, but it also has more safety warnings, including liver injury reports.

Does holy basil lower cortisol?

Not clearly. In the Holixer trial, hair cortisol, a marker of longer-term stress-hormone output, was lower at 8 weeks. It was not the trial’s main measure, was available for only 68 of the 100 participants, and produced an imprecise estimate. In the same trial, the change in cortisol during an acute stress test did not differ clearly between groups.

Drawbacks and side effects

There is no official upper limit. A 2017 review found that 15 studies reported no adverse events, eight did not describe them, and one reported occasional nausea.

The available trials were small and were not designed to detect uncommon liver harm. One trial measured liver enzymes without finding a statistically clear change; the review did not establish liver safety.

Fertility and medicine interactions

The fertility concern comes partly from animal research^[5]: male rabbits given 2 g of fresh leaves daily for 30 days had lower sperm counts. Human studies have not established the risk, a threshold dose or a recovery timetable. If you are trying to conceive, discuss regular medicinal use before starting it.

A 2026 laboratory study^[6] added an ethanolic leaf extract directly to platelets collected from human blood. It reduced their clumping response to collagen, a trigger used in the experiment. This helps explain the clotting concern, but it does not show how taking a capsule affects bleeding risk or interacts with a blood thinner.

Evidence for interactions with blood thinners is much less direct than evidence from a dedicated interaction trial. Tell the clinician managing anticoagulation or an upcoming operation that you use tulsi, including the preparation and dose; the available studies do not supply a universal stop date. With diabetes medicines, monitoring is prudent because glucose effects have been reported in some studies, though a dangerous interaction rate has not been established.

Pregnancy

Holy basil extracts have not been studied in pregnancy or breastfeeding, so skip them. Tea is a different and usually smaller amount, but it has not been established as safe in pregnancy either; ask the prenatal clinician before using it regularly.

The science behind holy basil

The strongest stress evidence comes from two small, maker-linked trials of different extracts. Additional studies examine cognition, glucose, lipids and immune markers, with different preparations and important gaps. A separate 2014 overview cited here was written by a paid adviser to tulsi maker Organic India.

Stress

In the OciBest trial, 158 adults with at least three stress symptoms were randomized and 150 were included in the symptom analysis. They took 1,200 mg of OciBest or a placebo for 6 weeks. Forgetfulness, exhaustion, sleep problems, and the total symptom score improved more with OciBest. The unfamiliar scoring method does not translate cleanly into a percentage of people who felt better.

In a 2022 Australian trial, 100 stressed adults took 125 mg of Holixer twice a day or a placebo for 8 weeks. Perceived stress fell 37 percent on Holixer and 19 percent on placebo.

Sleep

In the Holixer trial, the insomnia questionnaire improved more than with placebo. A second sleep questionnaire and the wrist-worn tracker did not show clear between-group differences. The result depends on which sleep measure is considered.

Anxiety and cognitive performance

A 2008 study in 35 patients with generalized anxiety disorder^[7] reported improvement after 500 mg of extract twice daily for 60 days. It was an open-label study without a placebo comparison, as described in the later Holixer report. Symptoms can change with time and expectations, so it supplies a weaker basis for treatment decisions than the controlled stress trials.

The 2015 cognition trial^[8] randomized 44 healthy men aged 18–30; 40 completed the study and were analyzed. The preparation was 300 mg/day of a leaf extract made using alcohol, containing more than 2.7% ursolic acid, for 30 days. The extract group did better on selected tests of short-term memory and cognitive flexibility, including speed and accuracy when responding to distracting information. Both groups improved with repeated testing, so practice contributed to the results.

Anxiety scores and salivary cortisol did not differ clearly between groups. The study therefore gives a narrow cognition signal in healthy young men, not a demonstrated treatment for anxiety or age-related cognitive decline. India’s All India Institute of Medical Sciences funded it; the Central Council for Research in Ayurveda and Siddha supplied the extract, and pharmaceutical company Dabur supplied placebo and handled coded packing.

Blood sugar and cholesterol

The 1996 diabetes trial abstract^[9] reports lower fasting and post-meal glucose during holy basil use than during the placebo period. It describes a randomized, single-blind crossover trial, but the accessible abstract does not specify the dose or participant count. Those missing details prevent a dependable product or dosing conclusion here.

A later pilot in 30 overweight or obese volunteers^[10] compared 250 mg of extract twice daily for eight weeks with no capsules. It was open-label. The abstract describes lower triglycerides, LDL cholesterol, insulin and an insulin-resistance estimate within the tulsi group. Those before-and-after changes are not the same as showing a greater improvement than the comparison group. HDL cholesterol was the lipid measure for which the abstract reports a significant between-group advantage.

The original indexed discussion also reports no significant fasting-glucose change. Taken together, these studies warrant further metabolic research.

Immunity and respiratory claims

In a small 2011 crossover trial^[11], 24 healthy volunteers received 300 mg of leaf extract made using alcohol or placebo, with 22 included in the analysis. After four weeks, the abstract reports changes in immune signalling proteins—interferon-gamma and interleukin-4—and in helper T cells and natural killer cells.

Those measurements describe immune activity. The trial did not establish that people caught fewer infections, recovered faster from a cold or had better asthma control. Traditional use for respiratory complaints and a change in an immune marker answer different questions.

How might tulsi affect stress?

One proposed explanation involves the communication between the brain and adrenal glands that regulates stress hormones. In 2023 experiments on Holixer^[12], researchers studied animal stress behaviours and cultured cells, finding effects on cortisol release and a receptor involved in stress signalling. All authors worked for the extract maker.

These experiments provide possible mechanisms to investigate. The human trials have not established that a particular constituent, such as eugenol, produces the clinical effect. Nor do they show that an ordinary tea delivers the same compounds at the same exposure as Holixer.

A 2017 review covered 24 human studies across these uses. Although every included study reported a favourable outcome, the authors also said the evidence was insufficient to recommend a particular formulation for a particular condition. Its safety discussion distinguished studies reporting no events from studies that did not describe adverse events at all.

The bottom line

Holy basil has two encouraging stress trials, but they tested different proprietary extracts and both had commercial connections. An improved insomnia score in one trial was not matched by a second sleep questionnaire or wrist-tracker sleep, so the result is more limited than a dependable sleep remedy.

The stress findings concern named extracts; tea and whole-leaf powder have different compositions. A small cognition trial adds an interesting signal, while metabolic and immune findings need fuller assessment before they can guide a product choice.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly